The SearchVoat Forum

So we have a new expert virologist who has popped up on social media in the last few days sounding the alarm about the mRNA vaccines - Dr. Geert Vandem Bossche. https://youtu.be/mUlDeCRDLnU

Mass Vaccination in a Pandemic - Benefits versus Risks: Interview with Geert Vanden Bossche https://youtu.be/ZJZxiNxYLpc

He's suddenly everywhere... .He opened an account on Twitter only this month https://twitter.com/GVDBossche

He has an extensive CV including working for the Bill and Melinda Gates Foundation between 2008 and 2011 :

"Responsible for operating Vaccine Programs (e.g., HIV-1, Malaria, TB, Polio...) and establishing international product development partnerships for immune interventions in Global Health (e.g., with Academia, Biotech Industry, NIH, Welcome Trust, WHO, PATH). Coordinating and spearheading international collaborations and consortia on innovative vaccine approaches and steering multidisciplinary vaccine initiatives"

Following one of his conversations on Linkedin where he shows complete disapproval for the policies recommended in this paper: Covid-19: Booster dose will be needed in autumn to avoid winter surge, says government adviser https://www.bmj.com/content/372/bmj.n664

That governor advisor is Anthony Harnden, Professor of Primary Care in the Nuffield Department of Primary Care Health Science and member of the Joint Committee of Vaccination and Immunisation since 2006, Chairman of the adolescent sub-committee. Based at St Hugh's College, University of Oxford https://www.phctrials.ox.ac.uk/team/anthony-harnden

Joint Committee on Vaccination and Immunisation https://en.wikipedia.org/wiki/Joint_Com ... munisation

The JCVI chairman is Professor Andrew Pollard of Oxford Vaccine Group in the Department of Paediatrics at the University of Oxford.[5] The chair of the COVID-19 subcommittee is Wei Shen Lim, a consultant respiratory physician and honorary professor of medicine at Nottingham University Hospitals NHS Trust..

The current members' names and affiliations are published online : HERE.

A previous chairman, Andrew Hall, was appointed Knight Bachelor in the 2013 Birthday Honours

Voat posts on Andrew Pollard https://searchvoat.co/search.php?t=%22a ... rd%22&b=on :

Vaccine data dump https://searchvoat.co/v/thinkdrafts/4052886

Andrew Pollard at the WHO https://www.who.int/immunization/sage/m ... ollard/en/

He runs surveillance for invasive bacterial diseases and studies the impact of pneumococcal vaccines in children in Nepal and leads a project on burden and transmission of typhoid in Nepal, Bangladesh and Malawi.

TyVAC Bangladesh: Typhoid Vaccine Trial - http://www.isrctn.com/ISRCTN11643110


The Nepalese scientific community is not very happy about the testing of vaccines on their children..

Prince William with Prof Pollard https://imgur.com/a/f1EVQu3

Another Gates Vaccine Bites the Dust-Sick Monkeys Everywhere! https://searchvoat.co/v/GreatAwakening/3840745

Andrew Pollard strikes again

"Pollard used his power and deceitful puffery about the monkey trial to bulldoze his COVID vaccine into human trials. He shunned inert placebo tests and restricted safety studies to three weeks to hide long-term injuries."

https://childrenshealthdefense.org/news ... ng/3840745

Gates and Fauci Back Down on Vaccine Promises https://searchvoat.co/v/Conspiracy/3929305/24774856

While vaccine developers have never dared to conduct testing against a true inert placebo as such tests would likely reveal safety problems, lead Oxford developer Andrew Pollard will now give trial participants a notoriously reactogenic meningitis vaccine as a “control”– a common ploy to mask injuries from experimental vaccines.

This is all anyone should need to hear about vavccines. The fuckers won't even truly test their products.

In the last few days I've been wondering about the role of the University of Oxford in all of this specifically to do with the current crop of buffoons, I mean politicians, who have emerged from that place.

Let's take Matt Hancock as an example. Dyslexic and clearly on the 'spectrum', he emerged with a First Class Degree in PPE from Exeter College, University of Oxford. Taking a closer look.. https://en.wikipedia.org/wiki/Matt_Hancock

Matthew John David Hancock was born on 2 October 1978 in Chester, Cheshire..Hancock attended Farndon County Primary School, in Farndon, Cheshire, and the independent King's School, Chester. He took A-levels in maths, physics, computing and economics.[5] He later studied computing at the further education college, West Cheshire College.[6][7] He studied at Exeter College, Oxford, and graduated with a first in philosophy, politics and economics, and earned a MPhil degree in Economics at Christ's College, Cambridge a few years later.

So after his A Levels he went on to study computing at a further education college.. and then OXFORD, leaving with a First? Anyone who knows the English education system knows how difficult, even unlikely, that would be.. maybe Daddy and Mummy were well connected? Or maybe the college has excellent programs?

2012 article: Olympic opening at West Cheshire College https://feweek.co.uk/2012/06/08/olympic ... e-college/

Sara Mogel, Principal of West Cheshire College said: “It was an evening that our guests and the College will remember for a long time.”

2014 article: Former college chief is ‘delighted’ https://www.cheshire-live.co.uk/news/ch ... ra-6458496

Former West Cheshire College principal Sara Mogel has been made an OBE for services to vocational education in the New Year’s Honours list. She retired from her post as principal of West Cheshire College in the spring of 2013 having worked in education for all of her career.
When she took over at West Cheshire College at the end of 2000 the college had property, financial and quality issues..

Wait.. If Matt Hancock was born in 1978 and attended the college after A levels (at around 18 years old) for 1 or 2 years he would have been leaving just as she was arriving at the college that had property, financial and quality issues.. then he went to Oxford?

"Young minister has the skills to climb to the top in Westminster" shouts the Financial Times in 2014 https://www.ft.com/content/027bd85e-029 ... 144feab7de

In this previous post I fleshed out the aristocratic links of his mother but never quite got to his father: Matt Hancock and Nicole Junkermann at the NHS https://searchvoat.co/v/thinkdrafts/3769255

Martha Hoyer Millar is a granddaughter paternally of the 1st Baron Inchyra, GCMG, CVO, (1900-89), & a niece of the 2nd Baron; & is a great-granddaughter (through her mother's maternal family) of the 1st Viscount Camrose.

Matt's father: Dr. Michael Hancock, Dee Associates https://find-and-update.company-informa ... 0/officers

Excerpts from the website of Dee Associates: https://www.dee-associates.com/insights ... 2490234375

Mike Hancock of Dee Associates chaired the Energy Efficiency 2018 Conference on 28th March 2018 in London. Speakers included prominent experts in the ISO 50001 Energy Management Standard, Government Policy and progress in meeting climate change goals, Artificial Intelligence, Behavioural Science and Green Finance. Mike is Chairman of the Energy Institute’s Energy Management Panel which organised the event.

Initiation of the HouseAFRICA Project - Dee Associates is helping to address the critical housing shortage in Africa by putting forward proposals to fund, build and manage low cost affordable housing on a large scale. A consortium of developers, builders and machinery experts met with Dee Associates at the Adelphi Hotel in Liverpool in April to commit resources to the urgent initiative of improving the lives of 1.2 billion people on the African continent.

Dee Associates Visit to University of Cape Town - Dee Associates visited the University of Cape Town in January 2018 to meet members of staff from the Department of Chemical Engineering and the local Branch of the IChemE. Dr Mike Hancock (centre right) gave a presentation on behalf of the University of Chester and explored opportunities for student exchange. Mike also delivered a paper reviewing the latest innovations in Energy Efficiency including the patented OxyGen energy from waste process. The background to the UK’s notable 40% reduction in greenhouse gas emissions was also discussed.

According to Mike Hancock's bio at Western Cape University:

Dr Hancock’s has a wealth of industrial experience, and also is a Visiting Lecturer in the department of Chemical Engineering at the University of Chester. His Ph.D. was from Cambridge under Nigel Kenney who specialised in reaction kinetics. He joined Shell to see the world --- and was sent to Manchester to train on the petrochemicals site at Carrington. He then moved to a new fertiliser production site next to nearby Stanlow refinery. After many years he joined ICI in a corporate planning role before embarking on consultancy. More recently he has focussed on industrial energy efficiency and has had the opportunity to visit a great many facilities large and small in different sectors. He is a Fellow of IChemE, Fellow of the Energy Institute, Chartered Engineer, member of the Register of Professional Energy Consultants and IRCA registered Auditor for the ISO 50001 Energy Management Standard.

Christopher Nigel KENNEY of Cambridge Reactor Design Ltd https://find-and-update.company-informa ... pointments

Company website : https://www.cambridgereactordesign.com/

They work with big pharma, including Pfizer and AstraZeneca : GlaxoSmithKline, Novartis, and AstraZeneca Fund Center Focused on Advancing Commercial-Scale Continuous Crystallization https://www.cambridgereactordesign.com/ ... _Oct13.pdf

Through partnerships and collaborations between academia, industry, and the public sector, the Center for Continuous Manufacturing and Crystallization is advancing continuous crystallization technologies.

CMAC was established in 2011 with support from founding members, such as GlaxoSmithKline (GSK),
Novartis, and AstraZeneca. Equipment is also provided by various engineering and instrumentation firms,
including Cambridge Reactor Design, NiTech Solutions, Amtech, Avantium Crystallization Systems, PSE, Perceptive Engineering, Clairet AWL, Mettler Toledo, and Bruker. There is broad engagement with other
pharmaceutical and fine-chemical companies, such as Pfizer, Sanofi (Genzyme), Fujifilm, Syngenta, and
Johnson Matthey, to name a few. The physical hub is at the University of Strathclyde (Glasgow), with
Glasgow, Heriot-Watt, Edinburgh, Cambridge, Loughborough, and Bath Universities rounding out the
multidisciplinary academic team. The center has raised nearly $100 million in two years, initiated several
research projects, implemented a doctoral training program across the network (45 PhD students), and is
starting a masters program..

. ..In one example, Perceptive Engineering, Astrazeneca, and the
Center for Process Innovation are working with CMAC to develop make-to-order processing plants
(MOPP). An automated control system is being installed on a Rattlesnake Oscillatory Flow Crystallizer
from Cambridge Reactor Design that will include in-line PAT systems (infrared, ultraviolet-visible, FBRM, and/or Raman spectroscopy) for monitoring and control. The system will first be evaluated for the cooling
crystallization of lactose in an aqueous solution, and then using a complex API in an organic solvent.

I think we're starting to work out what is Matt Hancock's personal stake in the AstraZeneca/Oxford vaccine... that's the vax that's currently suspended/banned in approximately 8 EU countries and the list is growing.

Siemens, Perceptive Engineering and PSE become partners in the Medicines Manufacturing Innovation Centre to advance continuous manufacturing https://www.uk-cpi.com/news/siemens-per ... ufacturing

27 AUG 2020
CPI has today announced the signing of partnership agreements with Siemens plc, Perceptive Engineering LTD and Process Systems Enterprise LTD (PSE), making them a part of the Medicines Manufacturing Innovation Centre collaboration...

The Medicines Manufacturing Innovation Centre is a collaboration between CPI, the University of Strathclyde and founding industry partners, GSK and AstraZeneca with funding provided by Scottish Enterprise and UK Research and Innovation.

David Lovett, Founder and Managing Director of Perceptive